We are live on
!
Find out more
HCM
Harvey Capital Management Portfolio holdings
AUM
$439M
1-Year Est. Return
37.68%
This Fund
S&P 500
This Quarter
Est. Return
+3.33%
1 Year Est. Return
+37.68%
3 Year Est. Return
+140.63%
5 Year Est. Return
+188.51%
10 Year Est. Return
+681.53%
AUM
$276M
AUM Growth
+$29.3M
(+12%)
Cap. Flow
+$23.1M
Cap. Flow
% of AUM
8.38%
Top 10 Holdings %
Top 10 Hldgs %
42.69%
Holding
85
New
11
Increased
37
Reduced
14
Closed
7
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Regeneron Pharmaceuticals
REGN
|
+$5.38M |
| 2 |
Becton Dickinson
BDX
|
+$3.78M |
| 3 |
Adobe
ADBE
|
+$3.76M |
| 4 |
PayPal
PYPL
|
+$3.44M |
| 5 |
Autodesk
ADSK
|
+$3.07M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$7.47M |
| 2 |
AT&T
T
|
+$4.01M |
| 3 |
PARA
Paramount Global Class B
PARA
|
+$3.63M |
| 4 |
Amplify Alternative Harvest ETF
MJ
|
+$1.91M |
| 5 |
ATVI
Activision Blizzard
ATVI
|
+$1.01M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 29.03% |
| 2 | Financials | 15.16% |
| 3 | Consumer Discretionary | 14.87% |
| 4 | Communication Services | 13.69% |
| 5 | Healthcare | 10.78% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
SPLK
76
DELISTED
Splunk Inc
SPLK
| $270K | 0.1% |
2,000
| – | – |
|
|
CGC
77
Canopy Growth
CGC
$410M
| $240K | 0.09% |
750
-100
| -12% | -$35.4K |
|
78
IDEX
IEX
$17.3B
| $235K | 0.09% |
1,125
| – | – |
|
79
iBio
IBIO
$70M
| – | – |
-150
| Closed | -$78K |
|
|
80
Amplify Alternative Harvest ETF
MJ
$105M
| – | – |
-11,094
| Closed | -$1.91M |
|
|
PARA
81
DELISTED
Paramount Global Class B
PARA
| – | – |
-97,581
| Closed | -$3.63M |
|
82
Viatris
VTRS
$19.1B
| – | – |
-17,560
| Closed | -$329K |
|
|
ALXN
83
DELISTED
Alexion Pharmaceuticals
ALXN
| – | – |
-47,806
| Closed | -$7.47M |
|
|
BFT
84
DELISTED
Foley Trasimene Acquisition Corp. II
BFT
| – | – |
-20,000
| Closed | -$302K |
|
|
BMY.RT
85
DELISTED
Bristol-Myers Squibb Company Contingent Value Rights
BMY.RT
| – | – |
-19,201
| Closed | -$13K |
|
Similar funds
CDMG
DCM
SCP
CAAM
SPT
BCM
VBA
BOA
Harvey Capital Management's Q1 2021 Portfolio in Review
As of Q1 2021, Harvey Capital Management held 85 positions worth $276M, up 12% from $246M the previous quarter. Its ten largest holdings account for 43% of the portfolio.
Harvey Capital Management deployed $23.1M of net new capital in Q1 2021, opening 11 new positions and adding to 37 existing holdings. Its largest new stake was Regeneron Pharmaceuticals: 11,057 shares worth $5.23M.
By sector, the portfolio is most concentrated in Technology at 29% of assets, up from 28% a quarter earlier, followed by Financials and Consumer Discretionary.
On the sell side, the largest reduction was AT&T, an estimated $4.01M trimmed.
- Harvey Capital Management's largest Q1 2021 buy was Regeneron Pharmaceuticals: 11,057 shares worth $5.23M.
- Harvey Capital Management added most to PayPal in Q1 2021, an estimated $3.44M increase.
- Harvey Capital Management's biggest Q1 2021 reduction was AT&T, cutting an estimated $4.01M.
- Harvey Capital Management fully exited Alexion Pharmaceuticals in Q1 2021, selling an estimated $7.47M.
- Harvey Capital Management's ten largest holdings make up 43% of its $276M portfolio in Q1 2021.
- Harvey Capital Management opened 11 new positions and closed 7 in Q1 2021.
- Harvey Capital Management's portfolio value rose 12% quarter-over-quarter to $276M.
Based on Harvey Capital Management's 13F filing for Q1 2021, filed 7 May 2021.